Progenika’s core business is the design and production of blood group genotyping for improvement in the safety of transfusion medicine. Established in 2001, Progenika Biopharma has been working closely with the European market for their use of BLOODchip®. In 2010, Progenika launched BLOODchipID® for higher throughput and cost effective molecular testing.
Products and Services
BLOODchipID product line consists of IDCore+, IDCore, and IDHPA BLOODchipID products used in conjuction with xMAP® Technology, allow Blood Banks to molecularly test for common and rare antigens.
200 Rivers Edge Drive
Medford, MA 02153